Apr 12, 2022, 08:45
Carbiotix (publ) ("Carbiotix" or "Company") announces today that the Company has started a nine-month evaluation project with a GroPro (www.groproab.se), a company focused on the production of pea protein with its first production site based at Food Hills in Bjuv, Sweden. An initial evaluation study conducted in the first quarter of 2022 demonstrated positive results to produce a prebiotic product from a side-stream separated fibre product in the production of pea protein. This project will therefore evaluate, in detail, the technical and economic feasibility of scaling up prebiotic production using the same fibre. The project will serve as a business case GroPro and also for other plant-based protein manufacturers around the world looking for more value adding applications for their side-stream fibre products.
Kristofer Cook, CEO of Carbiotix, comments
"I am very excited to announce this evaluation study and look forward to constructing our first business case for utilising side-stream fibre products separated from the pea protein manufacturing. The global vegan protein market is expected to reach a value of 17 Billion USD in the next five years. (1)
Fibre is today a side-stream product in the production of many vegan proteins and is typically sold by manufacturers as either an animal feed or for the production of other lower end food applications. Producing a higher-end prebiotic ingredient from this fibre is a much more appealing application for these side-stream products from a health, sustainability and financial perspective. Demonstrating a viable business case for the fibre in question will not only allow Carbiotix to potentially generate value through GroPro but also allow the Company to begin exploring other business opportunities from sidestream fibres generated from a global list of vegan protein manufacturers.”
This is information that Carbiotix AB is obliged to make public according to the EU Market Abuse Regulation (MAR). The information was made publicly available by the Company’s contact person set out below on 12 April 2022.
This communication contains forward-looking statements, consisting of subjective assumptions and forecasts for future scenarios. Predictions for the future only apply as of the date they are made and are, by their nature, as is research and development work in the biotechnology segment, associated with risk and uncertainty. With this in mind, the actual outcome may deviate significantly from the scenarios as described in this press release.
For further information:
Kristofer Cook, CEO
Tel: +46 (0)708-796580
Carbiotix AB (CRBX) (www.carbiotix.com) is an award-winning biotechnology company pioneering microbiome healthcare through a range of cost-effective gut health testing services and a portfolio of microbiome modulators covering prebiotic ingredients, medical foods and therapeutics.Go Back